Pt Bundamedik Tbk · IDX:BMHS
Pt Bundamedik Tbk — FY2022 Earnings Presentation
25 slides from Pt Bundamedik Tbk's earnings presentation, April 2023
Slide 1: PT Bundamedik Tbk – Analyst Meeting FY22 Results
PT Bundamedik Tbk Analyst Meeting – FY22 Results Apr 2023 Disclaimer: Presentation are intended for educational purposes only and do not replace independent professional judgement. Statements of fact and opinions are those of the participants individually and, unless expressly stated to the contrary
Slide 2: Leading Provider in Specialized Healthcare Services since 1973
Leading Provider in Specialized Healthcare Services since 1973
Slide 3: Bundamedik Tbk (BMHS) Ecosystem
Bundamedik Tbk (BMHS) Ecosystem Expanding Presence RSIA Az Zahra 9 HOSPITALS + 3 CLINICS Women & Children Hospitals 10 IVF CLINICS PADANG PONTIANAK BATAM 39 LABORATORIES Bunda Hospitals PALEMBANG MAKASSAR CLINICS NETWORK 200++ (KLINIK PINTAR) YOGYAKARTA 126 FERTILITY CLINICS NETWORK (KFI) Jakarta De
Slide 4: FY22 Key Highlights
FY22 Key Highlights Growth in core business, offsetting the decline in Covid earnings 1 3 Net Revenue Morula keeps expanding coverage -15% +73% vs 2021 vs Pre-Covid 2019 -2% +17% Followed with strong operational growth: # of IVF cycles # of IVF cycles vs vs 2021 Pre-Covid 2019 +24% # of Outpatients
Slide 5: FY22 Results
FY22 Results Expanding FY22 Results Presence Strategic Strengthening Partnership Our Core
Slide 6: Financial & Operational Performance
Financial & Operational Performance Flat QoQ growth; Gradual improvement post pandemic In Rp B, unless otherwise specified HIGHLIGHTS OF CONSOLIDATED RESULT 3Q22 4Q22 QoQ (%) FY22 FY21 YoY (%) HIGHLIGHTS HIGHLIGHTS OPERATIONALS 1 # Outpatient 131.2 134.6 3% 485.7 390.5 24% 1 Hospitals: operating met
Slide 7: Hospitals Volume
Hospitals Volume # OUTPATIENTS Existing # IP ADMISSION Existing Newly acquired Newly acquired +8% 485.7 120,8 124,0 +16% 34.4 7,8 7,6 383.1 359.6 390.5 104,3 101,7 6,7 6,6 22.1 19.6 21.3 1,4 2,0 1,9 5,8 8,1 10,4 10,6 0,5 1Q22 2Q22 3Q22 4Q22 2019 2020 2021 2022 2019 2020 2021 2022 1Q22 2Q22 3Q22 4Q22
Slide 8: Financial Performance
Financial Performance Consolidated NET REVENUE *) TOTAL EBITDA *) Core Revenue (Rp B) EBITDA Margin (Rp B,% Margin) 2022 Core Revenue Covid Revenue Non-Core EBITDA grew 17% YoY Core EBITDA 2022 Core EBITDA grew 17% YoY 2022 excl. newly acquired assets EBITDA Margin: 24% +20% -15% 1.710 +19% 1.461 -3
Slide 9: Balance Sheet
Balance Sheet Remains healthy CASH VS DEBT NET DEBT-TO-EBITDA (Rp B) (x) Net 418 -135 -216 225 Debt 830 855 2.2x 625 613 629 518 490 0.7x 100 -0.6x -0.4x 2019 2020 2021 2022 2019 2020 2021 2022 AR Days WORKING CAPITAL DAYS Inventory Days 58 AP Days 53 46 43 29 29 30 19 16 9 10 13 2019 2020 2021 2022
Slide 10: IVF Cycles
IVF Cycles Weak 4Q22 due to seasonality # OF IVF CYCLES (‘000) -2% 5.8 5.7 +17% 1.59 4.9 1.53 1.54 1.55 1.41 1.39 1.36 4.1 1.18 Jakarta 60% 55% Outside Jakarta 40% 45% FY19 FY20 FY21 FY22 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22
Slide 11: 2023 Initiatives: Morula
2023 Initiatives: Morula Improve internal business process Morula Dragon Baby Package in anticipation for Dragon year in 2024 Enhanced Brand Morula Positioning Enlarge Target Market including IVF Tourism Expand Business Ecosystem Advance technology Product
Slide 12: Diagnos: Growing Non-Covid Tests Offsetting Declining Covid Tests
Diagnos : Growing Non-Covid Tests Offsetting rapidly declining Covid Tests # OF TESTS (‘000) • Optimize footprint coverage to improve profitability +52% +16% • Market education to increase 888 766 genomics testing (Feb23 highest # to date vs 2022) 546 +32% FY22 Non Covid Test YoY • Develop central l
Slide 13: Expanding Presence
Expanding Presence Expanding FY22 Results Presence Strategic Strengthening Partnership Our Core
Slide 14: Recap of 2022
Recap of 2022 New Booking Platform Booking online and telemedicine Revamping Customer Journey Additional new hospitals Program with McKinsey for 3 months, pilot Additional 3 hospitals in 1H2022: project in RSIA Bunda Jakarta Menteng RSJP Paramarta, RSU Citra Harapan, RSIA Bunda Morula Surabaya Diagn
Slide 15: Strengthening Our Core
Strengthening Our Core Expanding FY22 Results Presence Strategic Strengthening Partnership Our Core
Slide 16: Employing Advanced Technology
Employing Advanced Technology Higher Success Rate Morula Services Higher Pregnancy Higher Pregnancy Success Rate Success Rate 68% 46% Morula is the first to offer PGT-A test which led to >50% success rate vs. non- 43% PGT-A1) 27% Fertility Wellness Fertility Acupuncture PGT-A is the latest leading t
Slide 17: Strengthening Our COEs
Strengthening Our COEs GynROSE Clinic Robotic Surgery Bunda Neuro Center Eras NICU/PICU Laparoskopi Bunda Health Center RSM Oncology Bunda General Hospital Bunda Women & Children Hospital Jakarta Klinik Tumbuh Kembang Anak Bunda Endoscopy Center
Slide 18: Ensuring Standardised Quality Process
Ensuring Standardised Quality Process
Slide 19: Strategic Partnership
Strategic Partnership Expanding FY22 Results Presence Strategic Strengthening Partnership Our Core
Slide 20: Enhancing Our Ecosystem: Klinik Fertilitas Indonesia (KFI)
Enhancing Our Ecosystem: Klinik Fertilitas Indonesia (KFI) Rising referral and conversion to IVF Treatment Morula strong presence through extensive KFI networks 126 KFI Partnership with local Obgyn clinics Clinics # PATIENTS REFERRED TO MORULA (x) • Efficient way to scale up Morula’s business +126%
Slide 21: 2023 Key Focus Area
2023 Key Focus Area 3 2 4 Improve the performance of 1 3 Optimize productivity and our newly acquired hospitals performance of our network: KFI (satellite clinics for Morula) and 1 Diagnos lab outlets 5 Continue with cost efficiency 2 Key Focus 4 Enhance our competitive edge initiatives to maintain
Slide 22: Expanding Presence
Expanding Presence New Hospitals and Clinics RSU Citra Harapan Bekasi Bunda Denpasar RSIA Azzahra Palembang Fully serve BPJS patients on Nov-22 Full Operation as Women and Children Hospital in On renovation until 3Q23 Mar-23 RS Bunda Morula Surabaya RSJP Paramartha Bandung RS Vida Bekasi On renovati
Slide 23: Our New Booking Platform
Our New Booking Platform onebunda.com 24
Slide 24: 2023 Network Planning
2023 Network Planning RSIA Bunda Jakarta Renovation RSIA Bunda Dewata Bunda Morula Nusa Dua
Slide 25: Thank You
THANK YOU Disclaimer: Presentation are intended for educational purposes only and do not replace independent professional judgement. Statements of fact and opinions are those of the participants individually and, unless expressly stated to the contrary. Specific data in this presentation was obtaine